CymaBay Therapeutics Inc.(CBAY)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CBAY CymaBay Therapeutics Inc.

停牌 05-15 05:48:13 EDT

32.48

+0.00

0.00%

最高32.48	最低32.48	成交量0.00
今开32.48	昨收32.48	日振幅0.00%
总市值37.29亿	流通市值31.19亿	总股本1.15亿
成交额2.71亿	换手率0.00%	流通股本9,603万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CBAY","market":"US","secType":"STK","nameCN":"CymaBay Therapeutics Inc.","latestPrice":32.48,"timestamp":1711051200000,"preClose":32.48,"halted":3,"volume":0,"delay":0,"floatShares":96025969,"shares":114811001,"eps":-0.992144,"marketStatus":"停牌","marketStatusCode":1,"change":0,"latestTime":"05-15 05:48:13 EDT","open":32.48,"high":32.48,"low":32.48,"amount":271432856.1804,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.992144,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715779800000},"adr":0,"listingDate":1403236800000,"adjPreClose":32.48,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/CBAY","defaultTab":"news","newsList":[{"id":"2411322694","title":"美国研究综述-布鲁克公司、Cymabay Therapeutics、SSR 矿业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411322694","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411322694?lang=zh_cn&edition=full","pubTime":"2024-02-14 15:35","pubTimestamp":1707896137,"startTime":"0","endTime":"0","summary":"    路透社2月14日 - 华尔街证券分析师周三调整了对布鲁克公司、Cymabay Therapeutics 和 SSR 矿业公司等几家美国上市公司的评级和目标价。要点             * 布鲁克公司  ：摩根大通将其评级从中性上调至增持             * Cymabay Therapeutics Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411338359","title":"美国研究综述-An2 Therapeutics、Par Technology、Trimble","url":"https://stock-news.laohu8.com/highlight/detail?id=2411338359","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411338359?lang=zh_cn&edition=full","pubTime":"2024-02-13 15:10","pubTimestamp":1707808204,"startTime":"0","endTime":"0","summary":"    路透社2月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 An2 Therapeutics、Par Technology 和 Trimble。公司要闻 * An2 Therapeutics Inc   ：Leerink Partners将其评级从 \"跑赢大盘 \"下调至 \"市场表现\"。* Par Technology Corp   ：Benchmark给予其 \"持有 \"评级 * Trimble Inc   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* Cymabay Therapeutics Inc   ：B. Riley 将目标价从 29 美元上调至 32.5 美元 * Cymabay Therapeutics Inc   ：Jonestrading将其目标价从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410684016","title":"Cymabay Therapeutics Inc盘中异动 大幅拉升24.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410684016","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410684016?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:31","pubTimestamp":1707748263,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时31分，Cymabay Therapeutics Inc股票出现异动，股价快速上涨24.25%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.42%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212223103878a0e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240212223103878a0e81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410847235","title":"BUZZ-CymaBay 因获吉利德 43 亿美元收购交易而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2410847235","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410847235?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:10","pubTimestamp":1707747019,"startTime":"0","endTime":"0","summary":"    2月12日 - ** 药物开发商CymaBay Therapeutics   股价盘前上涨24.6%，至32.0美元** 吉利德科学公司  表示，它将以43亿美元收购  CBAY，以扩大其肝病药物组合。** GILD 将向 CBAY 支付每股 32.50 美元的现金，比上周五收盘价溢价 26.5%。** 美国卫生监管机构已经接受了 CBAY 公司关于 seladelpar 的上市申请，正在进行优先审查，并将在 8 月 14 日之前决定该药物的用途。** 截至上次收盘，CBAY 公司的股价在过去 12 个月里上涨了两倍多。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2410555842","title":"吉利德将以 43 亿美元收购 CymaBay","url":"https://stock-news.laohu8.com/highlight/detail?id=2410555842","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2410555842?lang=zh_cn&edition=full","pubTime":"2024-02-12 21:33","pubTimestamp":1707744789,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社2月12日 - 吉利德科学公司  周一表示，将以43亿美元收购CymaBay Therapeutics  ，以扩大其肝病药物组合。CymaBay的股票在公告发布前的盘前时段停牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409743698","title":"Cymabay Therapeutics Inc盘中异动 大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409743698","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409743698?lang=zh_cn&edition=full","pubTime":"2024-02-08 23:14","pubTimestamp":1707405276,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日23时14分，Cymabay Therapeutics Inc股票出现波动，股价大幅上涨5.25%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.31%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208231436861d4bdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208231436861d4bdb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405677182","title":"Cymabay Therapeutics Inc盘中异动 下午盘股价大跌5.02%报23.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405677182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405677182?lang=zh_cn&edition=full","pubTime":"2024-01-23 03:23","pubTimestamp":1705951409,"startTime":"0","endTime":"0","summary":"北京时间2024年01月23日03时23分，Cymabay Therapeutics Inc股票出现波动，股价大幅跳水5.02%。截至发稿，该股报23.27美元/股，成交量103.133万股，换手率0.91%，振幅8.55%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.49%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123032329861cc7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123032329861cc7a0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402343406","title":"Cymabay Therapeutics Inc盘中异动 临近收盘股价大跌5.03%报23.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402343406","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402343406?lang=zh_cn&edition=full","pubTime":"2024-01-11 04:41","pubTimestamp":1704919294,"startTime":"0","endTime":"0","summary":"北京时间2024年01月11日04时41分，Cymabay Therapeutics Inc股票出现异动，股价急速下挫5.03%。截至发稿，该股报23.22美元/股，成交量84.2405万股，换手率0.74%，振幅5.52%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.28%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401110441357a3a0c8d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393936414","title":"Cymabay Therapeutics Inc盘中异动 快速上涨5.04%报23.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393936414","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393936414?lang=zh_cn&edition=full","pubTime":"2023-12-23 02:18","pubTimestamp":1703269101,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日02时18分，Cymabay Therapeutics Inc股票出现异动，股价快速拉升5.04%。截至发稿，该股报23.34美元/股，成交量62.3222万股，换手率0.55%，振幅4.86%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.67%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223021821861c6825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231223021821861c6825&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387044047","title":"Cymabay Therapeutics Inc盘中异动 早盘大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2387044047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387044047?lang=zh_cn&edition=full","pubTime":"2023-11-30 22:36","pubTimestamp":1701354997,"startTime":"0","endTime":"0","summary":"北京时间2023年11月30日22时36分，Cymabay Therapeutics Inc股票出现异动，股价大幅拉升5.01%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.18%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302236387a30afe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311302236387a30afe8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2385955854","title":"Cymabay Therapeutics Inc盘中异动 快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385955854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385955854?lang=zh_cn&edition=full","pubTime":"2023-11-24 23:12","pubTimestamp":1700838746,"startTime":"0","endTime":"0","summary":"北京时间2023年11月24日23时12分，Cymabay Therapeutics Inc股票出现波动，股价大幅上涨5.08%。Cymabay Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Scisparc Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Scisparc Ltd、Paxmedica Inc、Altamira Therapeutics Ltd较为活跃，换手率分别为1175.14%、206.48%、16.58%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Neximmune Inc、Scisparc Ltd，振幅分别为37.27%、34.89%、33.74%。Cymabay Therapeutics Inc公司简介：CymaBay Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为肝病和其他医疗需求未得到满足的慢性病患者开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231124231226839fdd87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231124231226839fdd87&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cymabay.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0093},{"period":"6month","weight":0.7856},{"period":"1year","weight":2.1231},{"period":"ytd","weight":0.3751}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.267},{"period":"ytd","weight":0.101}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cymabay Therapeutics, Inc.于1988年10月5日根据特拉华州的法律注册成立。CymaBay 治疗公司专注于开发治疗代谢和有大量需求的罕见疾病的疗法。其先导候选产品Arhalofenate，目前正在开发用于治疗痛风。Arhalofenate已经在痛风患者和一贯表现为有能力减少痛风发作和降低血清尿酸的患者中成功完成第三阶段的临床试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007141},{"month":2,"riseRate":0.7,"avgChangeRate":0.176948},{"month":3,"riseRate":0.5,"avgChangeRate":0.012224},{"month":4,"riseRate":0.333333,"avgChangeRate":0.044165},{"month":5,"riseRate":0.333333,"avgChangeRate":0.097143},{"month":6,"riseRate":0.555556,"avgChangeRate":0.00023},{"month":7,"riseRate":0.6,"avgChangeRate":0.018401},{"month":8,"riseRate":0.6,"avgChangeRate":0.118266},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012696},{"month":10,"riseRate":0.5,"avgChangeRate":0.009237},{"month":11,"riseRate":0.2,"avgChangeRate":-0.088054},{"month":12,"riseRate":0.7,"avgChangeRate":0.141932}],"exchange":"NASDAQ","name":"CymaBay Therapeutics Inc.","nameEN":"CymaBay Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CymaBay Therapeutics Inc.(CBAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CymaBay Therapeutics Inc.(CBAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CymaBay Therapeutics Inc.,CBAY,CymaBay Therapeutics Inc.股票,CymaBay Therapeutics Inc.股票老虎,CymaBay Therapeutics Inc.股票老虎国际,CymaBay Therapeutics Inc.行情,CymaBay Therapeutics Inc.股票行情,CymaBay Therapeutics Inc.股价,CymaBay Therapeutics Inc.股市,CymaBay Therapeutics Inc.股票价格,CymaBay Therapeutics Inc.股票交易,CymaBay Therapeutics Inc.股票购买,CymaBay Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CymaBay Therapeutics Inc.(CBAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CymaBay Therapeutics Inc.(CBAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况